Exane Derivatives’s Williams Partners L.P. WPZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-21
Closed -$850 737
2018
Q2
$850 Buy
21
+1
+5% +$38 ﹤0.01% 538
2018
Q1
$687 Sell
20
-3
-13% -$117 ﹤0.01% 489
2017
Q4
$891 Buy
23
+1
+5% +$38 ﹤0.01% 493
2017
Q3
$856 Sell
22
-1
-4% -$40 ﹤0.01% 463
2017
Q2
$922 Sell
23
-2
-8% -$80 ﹤0.01% 483
2017
Q1
$1.02K Sell
25
-5
-17% -$201 ﹤0.01% 414
2016
Q4
$1.14K Buy
30
+3
+11% +$108 ﹤0.01% 471
2016
Q3
$1K Sell
27
-107
-80% -$3.94K ﹤0.01% 481
2016
Q2
$4.64K Hold
134
﹤0.01% 396
2016
Q1
$2.74K Hold
134
﹤0.01% 452
2015
Q4
$3.73K Hold
134
﹤0.01% 371
2015
Q3
$4.28K Hold
134
﹤0.01% 383
2015
Q2
$6.49K Hold
134
﹤0.01% 386
2015
Q1
$6.59K Buy
+134
New +$6.54K ﹤0.01% 396

Other funds holding WPZ

Exane Derivatives's WPZ Position: Q3 2018 in Review

Exane Derivatives sold out of Williams Partners L.P. (WPZ) in Q3 2018, closing a stake of 21 shares — an estimated $850 sold.

Exane Derivatives first reported a position in WPZ in Q1 2015 and held it in 14 quarters. The position peaked at $6.59K in Q1 2015. 4 funds tracked by Wall St. Rank hold WPZ as of Q3 2018.

  • Exane Derivatives reported no remaining Williams Partners L.P. position as of Q3 2018 after selling out during the quarter.
  • Exane Derivatives sold 21 Williams Partners L.P. shares in Q3 2018, an estimated $850.
  • Exane Derivatives first reported a position in Williams Partners L.P. in Q1 2015 and held it in 14 quarters.
  • Exane Derivatives's Williams Partners L.P. position peaked at $6.59K in Q1 2015.
  • 4 funds tracked by Wall St. Rank held Williams Partners L.P. as of Q3 2018.

Based on Exane Derivatives's 13F filing for Q3 2018, filed 24 Oct 2018.